{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T04:22:30Z","timestamp":1743394950588,"version":"3.37.3"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate the clinimetric properties of the Academic Medical Centre Disability Score (ALDS) in patients with idiopathic inflammatory myopathy (IIM).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used prospectively collected data of IIM patients who completed a phase-2 study with first-line IVIG monotherapy. The ALDS is a patient-reported questionnaire which contains 25 items relevant for disability in myositis. ALDS and all core set measures (CSMs) for myositis [including HAQ-Disability Index (HAQ-DI)] were evaluated at baseline and 9\u2009weeks follow-up. In addition, the 2016 ACR\/EULAR myositis response criteria outcome called Total Improvement Score (TIS) was evaluated at 9\u2009weeks. We examined floor\/ceiling effects, reliability and construct validity of the ALDS. To examine known-group validity, ALDS change scores over time were compared with TIS and physician impression of clinical response.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Nineteen patients with IIM [median age 59\u2009years, 12 (63%) female] were enrolled. At baseline, ALDS showed a median score of 65.4 (IQR 58.2\u201373.5), good Cronbach\u2019s alpha (\u03b1\u2009=\u20090.84) and a small ceiling effect (11%). Construct validity was confirmed by moderate to strong correlations between ALDS and HAQ-DI [rs\u2009=\u2009\u22120.57 (baseline); \u22120.86 (follow-up)]. ALDS change score correlated with TIS (rs\u2009=\u20090.70), discriminated between responders and non-responders (TIS\u2009\u2265\u200940; P\u2009=\u20090.001), between groups based on physician impression of clinical response (P\u2009=\u20090.03), and detected deterioration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The ALDS showed promising clinimetric properties and detected relevant changes in disability in patients with myositis. These results warrant further investigations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab906","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T12:57:40Z","timestamp":1638449860000},"page":"3420-3426","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of disability in idiopathic inflammatory myopathy: a call for linearity"],"prefix":"10.1093","volume":"61","author":[{"given":"Minoesch","family":"Min","sequence":"first","affiliation":[{"name":"Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-0508","authenticated-orcid":false,"given":"Anne W","family":"Walter","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7565-1954","authenticated-orcid":false,"given":"Johan","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Eftimov","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camiel","family":"Verhamme","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"de Visser","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo N","family":"van Schaik","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience"},{"name":"Spaarne Gasthuis , Haarlem, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine , Pittsburgh, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob J","family":"de Haan","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam , Amsterdam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneke J","family":"van der Kooi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Raaphorst","sequence":"additional","affiliation":[{"name":"Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Dutch Myositis Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiaan G J","family":"Saris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Brusse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica E","family":"Hoogendijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"2022080318252775300_keab906-B1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nrrheum.2018.33","article-title":"Update on outcome assessment in myositis","volume":"14","author":"Rider","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2022080318252775300_keab906-B2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.nmd.2016.05.014","article-title":"213th ENMC International Workshop: outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015","volume":"26","author":"Benveniste","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"2022080318252775300_keab906-B3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/art.40064","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an international myositis assessment and clinical studies group\/paediatric rheumatology international trials organisation collaborative initiative","volume":"69","author":"Aggarwal","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2022080318252775300_keab906-B4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s10067-005-0075-3","article-title":"Characterization of relapses in adult idiopathic inflammatory myopathies","volume":"25","author":"Agarwal","year":"2006","journal-title":"Clin Rheumatol"},{"key":"2022080318252775300_keab906-B5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3899\/jrheum.180353","article-title":"Perceptions of patients, caregivers, and healthcare providers of idiopathic inflammatory myopathies: an international OMERACT study","volume":"46","author":"Mecoli","year":"2019","journal-title":"J Rheumatol"},{"key":"2022080318252775300_keab906-B6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/0146621616664046","article-title":"Comparison of classical test theory and item response theory in individual change assessment","volume":"40","author":"Jabrayilov","year":"2016","journal-title":"Appl Psychol Meas"},{"key":"2022080318252775300_keab906-B7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1025824810390","article-title":"Constructing an item bank using item response theory: the AMC linear disability score project","volume":"4","author":"Holman","year":"2003","journal-title":"Health Services Outcomes Res Methodol"},{"key":"2022080318252775300_keab906-B8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1477-7525-3-83","article-title":"The Academic Medical Center Linear Disability Score (ALDS) item bank: item response theory analysis in a mixed patient population","volume":"3","author":"Holman","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"2022080318252775300_keab906-B9","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1212\/01.wnl.0000295666.30948.9d","article-title":"The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease","volume":"69","author":"Weisscher","year":"2007","journal-title":"Neurology"},{"key":"2022080318252775300_keab906-B10","first-page":"1222","article-title":"The Academic Medical Center Linear Disability Score item bank: psychometric properties of a new generic disability measure in rheumatoid arthritis","volume":"34","author":"Weisscher","year":"2007","journal-title":"J Rheumatol"},{"key":"2022080318252775300_keab906-B11","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/rheumatology\/keaa459","article-title":"Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study","volume":"60","author":"Lim","year":"2021","journal-title":"Rheumatology"},{"key":"2022080318252775300_keab906-B12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"year":"2019","key":"2022080318252775300_keab906-B13"},{"key":"2022080318252775300_keab906-B14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1477-7525-2-29","article-title":"Practical methods for dealing with \u2018not applicable\u2019 item responses in the AMC Linear Disability Score project","volume":"2","author":"Holman","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"2022080318252775300_keab906-B15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","article-title":"User's guide to correlation coefficients","volume":"18","author":"Akoglu","year":"2018","journal-title":"Turk J Emerg Med"},{"key":"2022080318252775300_keab906-B16","volume-title":"Psychometric theory","author":"Nunnally","year":"1978","edition":"2nd edn"},{"key":"2022080318252775300_keab906-B17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"2022080318252775300_keab906-B18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.nmd.2013.06.006","article-title":"196th ENMC international workshop: outcome measures in inflammatory peripheral neuropathies 8-10 February 2013, Naarden, The Netherlands","volume":"23","author":"Vanhoutte","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"2022080318252775300_keab906-B19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(17)30378-2","article-title":"Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"van Schaik","year":"2018","journal-title":"Lancet Neurol"},{"key":"2022080318252775300_keab906-B20","first-page":"446","article-title":"The MACTAR Patient Preference Disability Questionnaire\u2013an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis","volume":"14","author":"Tugwell","year":"1987","journal-title":"J Rheumatol"},{"key":"2022080318252775300_keab906-B21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1745-3992.1993.tb00543.x","article-title":"Comparison of classical test theory and item response theory and their applications to test development","volume":"12","author":"Hambleton","year":"2005","journal-title":"Educ Measur Issues Pract"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab906\/42259363\/keab906.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/8\/3420\/45226982\/keab906.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/8\/3420\/45226982\/keab906.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T18:26:03Z","timestamp":1659551163000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/8\/3420\/6454962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,12,7]]},"published-print":{"date-parts":[[2022,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab906","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2021,12,7]]}}}